Intraocular lenses when used to replace a patient’s natural lens of the eye are only licensed in Canada to treat cataracts. They are not licensed to replace lenses in patients without cataracts, and come with risks. HMC
Tag: risk
Post
Myocarditis Risk
Since May 2021, the Public Health Agency of Canada has been actively monitoring reports of myocarditis and pericarditis following vaccination with COVID-19 mRNA vaccines through passive and active Canadian safety surveillance systems. Available information from international reports, including those from Israel and the United States, indicated that: cases were more commonly reported after the second dose, and...
Post
Astra Zeneca and blood clot risk in Europe
Health Canada has issued the following advisory statement “ Health Canada is aware of reports of adverse events in Europe following immunization with the AstraZeneca COVID-19 vaccine, and would like to reassure Canadians that the benefits of the vaccine continue to outweigh its risks. Health Canada authorized the vaccine based on a thorough, independent review...
Post
Health Canada warns Canadians not to buy COVID-19 vaccines sold online or from unauthorized sources
Health Canada is warning Canadians not to buy COVID-19 vaccines sold on the internet or from unauthorized sources as they are counterfeit. Counterfeit COVID-19 vaccines may pose serious health risks, and are ineffective at protecting an individual from the COVID-19 virus. HMC
Post
PICATO (ingenol mebutate gel, 0.015% and 0.05%) – Product Withdrawal in Canada due to Potential Increased Risk of Skin Cancer
At Health Canada’s request, LEO Pharma Inc. is withdrawing Picato from the Canadian market. This follows a safety review by the Department, which concluded that use of Picato may be associated with an increased risk of non-melanoma skin cancer, and that the benefits of using Picato no longer outweigh its potential risks. HMC
Post
Recall of certain hand sanitizers that contain technical-grade ethanol
Health Canada is advising Canadians that certain lots of the following hand sanitizer are being recalled from the market because they contain ethanol or denaturants that are not acceptable for use in hand sanitizers in Canada. Product Unacceptable Ingredient Recalling Company NPN or DIN Lot numbers Expiry Date Date Added Clean & Green Hand Sanitizer...
Post
COVID-19
The first two cases in Peel Region were tested positive on March 4th who were a couple aboard Grand Princess Cruise Ship from February 11- 21 out of San Fransisco. Both are recovering at home in self-isolation. The risk to the public remains low. There is no evidence that COVID-19 is circulating in the community....
Post
Caution when taking Gabapentin or Pregabalin with Opioids
Health Canada is advising Canadians about the increased risk of opioid overdose and serious side effects when taking gabapentin (e.g., Neurontin) or pregabalin (e.g., Lyrica) with an opioid. HMC
Post
Health products manufactured by Professional Botanicals Inc. may pose serious health risks
Health Canada is warning that all products manufactured by Professional Botanicals Inc. may pose serious health risks. The company is a contract manufacturer that also operates under the name Healthy Botanicals Inc. HMC
Post
Misuse and Abuse of Antidiarrheal Loperamide- January 2018
FDA announced new action to combat the growing problem of abuse and misuse of the opioid-based antidiarrheal medication loperamide (Imodium). In 2016, the FDA warned about life-threatening cardiac events, including QT interval prolongation, torsades de pointes or other ventricular arrhythmias, syncope, and cardiac arrest, with loperamide misuse and abuse. The FDA notes that some individuals...